Study of Long-term HFNC for COPD Patients With HOT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a prospective, randomized parallel study for evaluation of the efficacy and safety of long-term nocturnal high-flow nasal cannula therapy (HFNC: with the myAIRVO2 as HFNC in this study) in stable COPD patients with the global initiative for chronic obstructive lung disease (GOLD) stage 2-4, PaCO2 \>= 45 Torr and hypercapnia who require home oxygen therapy (HOT) using COPD exacerbation (Moderate or Severe).
Epistemonikos ID: bbe0bea8421379080714cc4afca8e46f3a18dbb2
First added on: May 21, 2024